AntonioMGottoMD

Professor of Medicine, Cornell University-Weill Medical College

Overview of Dr. Gotto

Dr. Antonio Gotto is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 52 years. He is one of 695 doctors at New York-Presbyterian Hospital and one of 695 doctors at New York-Presbyterian Hospital who specialize in Cardiology. He has more than 100 publications and over 500 citings.

Office
520 E 70th St
# ST-4
New York, NY 10021
Book by Phone+1(928) 440-8857

Fax+1 212-746-8451

Education & Training

Massachusetts General HospitalResidency, Internal Medicine, 1966 - 1967
Massachusetts General HospitalInternship, Transitional Year, 1965 - 1966
Vanderbilt University School of MedicineClass of 1965

Certifications & Licensure

NY State Medical License 1997 - 2026
TX State Medical License 1972 - 2025
MD State Medical License 1969 - 2000
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Elected Member Institute of Medicine, 1991
Elected Member The American Society for Clinical Investigation, 1971
Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

4460 citations
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Paul M. Ridker, Eleanor Danielson, Jacques Genest, Antonio M. Gotto, Wolfgang Koenig
The New England Journal of Medicine. 2008-11-20
1191 citations
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.
Paul M. Ridker, Nader Rifai, Michael Clearfield, John R. Downs, Stephen E. Weis
The New England Journal of Medicine. 2001-06-28
755 citations
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Paul M. Ridker, Eleanor Danielson, Francisco Ah Fonseca, Jacques Genest, Antonio M. Gotto
Lancet. 2009-04-04

Journal Articles

Association of Bempedoic Acid Administration with Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients with Hypercholesterolemia
Antonio M Gotto, Zhan Ye, JAMA Cardiology

Authored Content

ACC 2021: Updates in Treating DyslipidemiaJune 2021
Association of Bempedoic Acid Administration with Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients with HypercholesterolemiaJuly 2020
Association of Bempedoic Acid Administration with Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients with HypercholesterolemiaJuly 2020

Press Mentions

Bending Ethics to Suit Predetermined Hypotheses – Prof Noakes on Ancel Keys’ Cholesterol ConNovember 10th, 2022
Intensive Lipid-Lowering Slashes CVD in Elderly ACS PatientsJuly 19th, 2019
Higher Intensity Therapy with Simvastatin-Ezetimibe May Benefit Elderly Patients After ACSJuly 18th, 2019
Join now to see all